Perbak Capital Partners »

Axsome Therapeutics shares owned by Perbak Capital Partners

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Perbak Capital Partners from 13F filings

Historical chart of Perbak Capital Partners investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Perbak Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Perbak Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $767k 6.3k 121.45
2025-06-30 $494k 4.7k 104.39

More positions owned by Perbak Capital Partners

Select Sector Spdr Tr Indl (XLI)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Ishares Tr Russell 2000 Etf (IWM)
Spdr Series Trust S&p Ins Etf (KIE)
Select Sector Spdr Tr Technology (XLK)
Elanco Animal Health (ELAN)
Ishares Tr Ishares Semicdtr (SOXX)
Select Sector Spdr Tr Financial (XLF)
Ubs Group SHS (UBS)
Qiagen Nv Com Shs (QGEN)
D.R. Horton (DHI)
Mettler-Toledo International (MTD)

View all positions for Perbak Capital Partners

Top funds holding Axsome Therapeutics

Vanguard Group
BlackRock
Wellington Management Company
Rtw Investments
Macquarie Group
Geode Capital Management
Invesco
State Street Corporation
FMR
Deep Track Capital
Fairmount Funds Management
Eventide Asset Management
Alethea Capital Management
Susquehanna International
OrbiMed Advisors

View all funds holding Axsome Therapeutics